Refine by
Hip Knee Articles & Analysis: Older
29 news found
Introduction Intraoperative irrigation is a commonly used method aimed at reducing microbial burden by removing tissue debris, metabolic waste, and tissue exudate from the surgical field prior to site closure.1 With the absence of universally established standard of care and robust clinical data, the selection of appropriate irrigation solution remains a topic of debate. Isotonic saline has ...
” According to Dr Jeffery, orthopaedic devices for upper extremities, in particular the hand and wrist, have largely been ignored by the major orthopaedics companies in favour of the high volume, high price hip and knee markets. The lack of innovation in hand and wrist orthopaedic devices has left hand and wrist surgeons under-served with a lack of ...
Rivaroxaban Rivaroxaban, as an antithrombotic drug, is widely used in the treatment and prevention of deep vein thrombosis (DVT) symptoms prior to hip or knee replacement surgery, treatment of venous thromboembolism (VTE) and nonvalvular atrial fibrillation, as well as treatment of DVT and pulmonary embolism (PE). ...
Over 1 million partial meniscectomies to remove or repair a torn meniscus are performed in the U.S. every year, about the same as the total number of hip and knee replacement surgeries combined. However, many patients still experience persistent knee pain following meniscus surgery. “Current treatments for meniscus-related chronic ...
Four years ago, Marchand tore the meniscus in his left knee while practicing Brazilian Jiu-Jitsu drills, only to suffer a second tear in the same knee in 2014 while jogging. ...
[ii] Patients undergoing major surgeries like hip or knee replacements face the risk of life-threatening infections – with the majority of these related to the patients’ own microflora. ...
Significant findings of Evoke ECAP-controlled closed-loop in the EVOKE Study at 24 months include: Superiority in treatment of overall back and leg pain and long-term pain reduction Highest long-term responder (≥50% relief) and high responder (≥80% relief) rates, 84% and 50%, respectively Highest reported improvements in overall quality of life, pain relief, ability to perform daily ...
” MicroPort Orthopedics offers various products and techniques to help patients receiving total hip and knee replacements achieve Full Function, Faster. About MicroPort Orthopedics MicroPort Orthopedics leverages extensive experience in orthopedics and excellent clinical results to improve patient outcomes and drive provider satisfaction across the globe. ...
THINK Surgical, Inc., a leading innovator in the field of orthopedic robotic surgery, announced that Golden Valley Memorial Healthcare (GVMH) in Clinton, MO is among the first healthcare facilities to employ the second-generation TSolution One® robot for total knee arthroplasty (TKA). James Womack, M.D., a board-certified orthopedic surgeon and fellow of the American ...
Barnes is a board-certified, fellowship-trained total joint surgeon with a special interest in hip and knee replacement surgery. His extensive expertise as an innovative thought leader and educator has greatly influenced the global orthopedic industry. ...
Vincent Charity Medical Center in Cleveland is among the first healthcare facilities in the United States and the first healthcare facility in Ohio to utilize the second-generation TSolution One® Total Knee Application for total knee arthroplasty (TKA). Bernard Stulberg, M.D., a renowned orthopedic surgeon, performed the first procedure with the new system on ...
KiOmed Pharma, an innovative Belgian biotech company, has reported positive safety and efficacy outcomes following the treatment of nearly 80 patients suffering from Knee OsteoArthritis (OA). This European Healthcare Professional (HCP) survey yielded a global long-term improvement of OA symptoms and shows preliminary evidence of improved outcomes in patients with advanced stage ...
Ortho Development Corporation (ODEV) hosted the bi-annual Utah Hip and Knee Arthroplasty Symposium (UHKAS) in Park City, Utah on April 14-17, 2021. ...
The aim of their research was developing a way to effectively restore damaged cartilage that leads to osteoarthritis in the hip, knee and other joints in the body. This work led to forming Cytex Therapeutics and development of implants that Cytex plans to take into clinical studies later this year. ...
In June 2020, ODEV signed an exclusive distribution agreement with WASTON for the sale of its total knee replacement product, the Balanced Knee® System (BKS), in China. ...
Its technology is FDA-cleared to treat all musculoskeletal patients, and currently offers rehabilitation programs for chronic, acute, and post-surgical conditions of the lower back, shoulder, neck, knee, elbow, hip, ankle, wrist, and lungs. “SWORD Health outshines every other virtual musculoskeletal solution that has emerged over the last few years,” ...
The solution extends SWORD Health’s clinical-grade virtual MSK care program, which provides non-invasive relief for chronic and post-surgical conditions of the lower back, shoulder, neck, knee, elbow, hip, ankle and lungs through therapeutic exercise, education, behavioral coaching and Cognitive Behavioral Therapy. ...
Digital tomosynthesis with the X Twin RF enables the use of different scanning angles and the reconstruction of different finely resolved layer thicknesses between 1 and 10 mm, depending on the requirements for the imaging of different body regions (thorax, hip, knee, foot, ...). The start and end position can be adjusted according to the user's special needs to ...
Juanto’s study shows that, left untreated, pediatric flatfeet persist into adulthood and are a leading cause of secondary deformities within the feet, knee, hips, and back. The study further shows that typical treatments fail to fix the main issue; the partial dislocation of the ankle bone. ...
Alkahest, Inc., a clinical stage biotechnology company focused on developing transformative therapies to treat age-related diseases, today announced the dosing of the first patient in AKST6021-211, a phase 2 clinical trial of its proprietary human plasma fraction, GRF6021, administered before and after primary hip or knee arthroplasty, to provide key insights ...